Publication: Glial activation and midkine and pleiotrophin transcription in the ventral tegmental area are modulated by morphine administration
| dc.contributor.author | García Pérez, Daniel | |
| dc.contributor.author | Núñez Parra, Cristina | |
| dc.contributor.author | Laorden Carrasco, María Luisa | |
| dc.contributor.author | Milanés Maquilón, María Victoria | |
| dc.contributor.department | Farmacología | |
| dc.contributor.other | Farmacia | |
| dc.date.accessioned | 2026-02-24T08:02:37Z | |
| dc.date.available | 2026-02-24T08:02:37Z | |
| dc.date.copyright | © 2014, Elsevier B.V. All rights reserved | |
| dc.date.issued | 2014-07-30 | |
| dc.description.abstract | Opiates cause persistent restructuring in the mesolimbic reward system. Although a possible role for midkine and pleiotrophin cytokines in the field of synaptic plasticity has been proposed, it has not been assessed whether morphine administration regulates astrogliosis and midkine and pleiotrophin transcription. We observed that single morphine injection and chronic morphine increased glial fibrillary acidic protein expression in the ventral tegmental area (VTA). Interestingly, single morphine injection and chronic morphine increased VTA midkine and pleiotrophin mRNA expression. Given these results, we hypothesize a role for these cytokines in mediating, at least in part, acute neuroprotective effects and chronic neurotrophic adaptations that contribute to drug dependence. | |
| dc.format | application/pdf | |
| dc.format.extent | 24 | |
| dc.identifier.citation | García-Pérez D, Luisa Laorden M, Núñez C, Victoria Milanés M. Glial activation and midkine and pleiotrophin transcription in the ventral tegmental area are modulated by morphine administration. J Neuroimmunol. 2014 Sep 15;274(1-2):244-8. doi: 10.1016/j.jneuroim.2014.07.017 | |
| dc.identifier.doi | https://doi.org/10.1016/j.jneuroim.2014.07.017 | |
| dc.identifier.eissn | 1872-8421 | |
| dc.identifier.issn | 0165-5728 | |
| dc.identifier.uri | http://hdl.handle.net/10201/211401 | |
| dc.language | eng | |
| dc.publisher | Elsevier | |
| dc.relation | This work was supported by grants from Ministerio de Ciencia e Innovación (SAF/FEDER 2009-07178; SAF/FEDER 2010-17907), Spain; Red de Trastornos Adictivos (RETICS, RD12/0028/0003), Spain; Fundación Séneca (15405/PI/10), Región de Murcia, Spain. Daniel García-Pérez was supported by a fellowship from Ministerio de Ciencia e Innovación (AP2009-2379). | |
| dc.relation.publisherversion | https://www.sciencedirect.com/science/article/pii/S016557281400232X?via%3Dihub | |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | * |
| dc.rights.accessRights | info:eu-repo/semantics/openAccess | |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
| dc.subject | Reward pathway | |
| dc.subject | Glial fibrillary acidic protein | |
| dc.subject | Midkine | |
| dc.subject | Pleiotrophin | |
| dc.subject | Opiate dependence | |
| dc.subject.ods | No relacionado con ningún objetivo de desarrollo sostenible | |
| dc.title | Glial activation and midkine and pleiotrophin transcription in the ventral tegmental area are modulated by morphine administration | |
| dc.type | info:eu-repo/semantics/article | |
| dc.type.version | info:eu-repo/semantics/acceptedVersion | |
| dspace.entity.type | Publication | es |
| relation.isAuthorOfPublication | 2f2500a1-1b27-4420-820c-db8c16e79afd | |
| relation.isAuthorOfPublication | 353c85df-d611-4999-b8b7-960dd35d1011 | |
| relation.isAuthorOfPublication | a28169ff-757a-4fa6-a2c9-687ece58e422 | |
| relation.isAuthorOfPublication | 3563e5e9-0816-46a5-be3d-af02c0458d91 | |
| relation.isAuthorOfPublication.latestForDiscovery | 2f2500a1-1b27-4420-820c-db8c16e79afd |
Collections
Este ítem está sujeto a una licencia Creative Commons. http://creativecommons.org/licenses/by-nc-nd/4.0/